111 related articles for article (PubMed ID: 3480794)
1. Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model.
Arkesteijn GJ; Martens AC; Jonker RR; Hagemeijer A; Hagenbeek A
Cytometry; 1987 Nov; 8(6):618-24. PubMed ID: 3480794
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of flow karyotyping in myelocytic leukemia by stimulation of different subpopulations of cells in blood or bone marrow samples.
Arkesteijn GJ; van Dekken H; Martens AC; Hagenbeek A
Cytometry; 1990; 11(1):196-201. PubMed ID: 2307058
[TBL] [Abstract][Full Text] [Related]
3. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
Martens AC; Van Bekkum DW; Hagenbeek A
Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
Martens AC; van Bekkum DW; Hagenbeek A
Int J Cell Cloning; 1990 Jan; 8(1):27-38. PubMed ID: 2403582
[TBL] [Abstract][Full Text] [Related]
5. [Minimum residual leukemic cells in genetically marked brown Norway rat myelocytic leukemia model].
Yan Y; Martens AC; Van Bekkum DW
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):414-7. PubMed ID: 1304472
[TBL] [Abstract][Full Text] [Related]
6. Detection of minimal disease in acute leukemia using flow cytometry: studies in a rat model for human acute leukemia.
Martens AC; Hagenbeek A
Cytometry; 1985 Jul; 6(4):342-7. PubMed ID: 3860369
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
[TBL] [Abstract][Full Text] [Related]
8. Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
Martens AC; de Groot CJ; Hagenbeek A
Eur J Cancer; 1991; 27(2):161-6. PubMed ID: 1827281
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease in leukemia: state of the art 1991.
Hagenbeek A
Leukemia; 1992; 6 Suppl 2():12-6. PubMed ID: 1578911
[TBL] [Abstract][Full Text] [Related]
10. Bivariate flow karyotyping in human Philadelphia-positive chronic myelocytic leukemia.
Arkesteijn GJ; Martens AC; Hagenbeek A
Blood; 1988 Jul; 72(1):282-6. PubMed ID: 3164636
[TBL] [Abstract][Full Text] [Related]
11. Bivariate flow karyotyping, sorting, and peak assignment of all rat chromosomes.
Shepel LA; Morrissey LW; Hsu LC; Gould MN
Genomics; 1994 Jan; 19(1):75-85. PubMed ID: 8188245
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
Martens AC; Johnson RJ; Kaizer H; Hagenbeek A
Exp Hematol; 1984 Sep; 12(8):667-71. PubMed ID: 6386506
[TBL] [Abstract][Full Text] [Related]
13. In vivo development of an acetyldinaline resistant subline of the BN rat acute myelocytic leukemia (BNML).
el-Beltagi HM; Martens AC; Haroun EA; Hagenbeek A
Leukemia; 1993 Aug; 7(8):1275-80. PubMed ID: 8350629
[TBL] [Abstract][Full Text] [Related]
14. A subline of the Brown Norway myeloid leukemia in the Lewis x Brown Norway rat: in vivo growth characteristics and development of an in vitro clonogenic assay.
Wiley JM; Yeager AM; Johnson RJ; Lanotte M
Int J Cell Cloning; 1989 Sep; 7(5):292-302. PubMed ID: 2788672
[TBL] [Abstract][Full Text] [Related]
15. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD).
Yan Y; Martens AC; de Groot CJ; Hendrikx PJ; Valerio D; van Bekkum DW; Hagenbeek A
Leukemia; 1993 Jan; 7(1):131-9. PubMed ID: 8418372
[TBL] [Abstract][Full Text] [Related]
17. Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia. II. Velocity sedimentation in combination with density gradient separation.
Hagenbeek A; Martens AC
Exp Hematol; 1981 Jul; 9(6):573-80. PubMed ID: 6943036
[No Abstract] [Full Text] [Related]
18. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
[TBL] [Abstract][Full Text] [Related]
19. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
[TBL] [Abstract][Full Text] [Related]
20. Chromosome abnormalities in leukemia and lymphoma.
Rowley JD
Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
